Founder Arun Kumar is back in the driver’s seat at Strides Pharma Science Limited and at the first analyst meet post resumption of his role as managing director, outlined a recalibration strategy that saw the company exit Canada and a few European markets while continuing to be upbeat about the US.
In FY23, conserving cash will likely be high on the agenda as the company tries to fight repercussions of the...